Highlander Capital Management Cut Cvs Health Com (CVS) Position as Stock Price Declined; General Mills (GIS) Market Valuation Declined While Matrix Asset Advisors Upped by $760,461 Its Holding

February 18, 2018 - By Stephen Andrade

Highlander Capital Management Llc decreased its stake in Cvs Health Corp Com (CVS) by 67.2% based on its latest 2017Q3 regulatory filing with the SEC. Highlander Capital Management Llc sold 4,200 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 2,050 shares of the medical and nursing services company at the end of 2017Q3, valued at $167,000, down from 6,250 at the end of the previous reported quarter. Highlander Capital Management Llc who had been investing in Cvs Health Corp Com for a number of months, seems to be less bullish one the $72.84B market cap company. The stock increased 2.00% or $1.41 during the last trading session, reaching $71.9. About 6.47M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 18, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Matrix Asset Advisors Inc increased its stake in General Mills (GIS) by 12.72% based on its latest 2017Q3 regulatory filing with the SEC. Matrix Asset Advisors Inc bought 14,911 shares as the company’s stock declined 5.07% while stock markets rallied. The institutional investor held 132,090 shares of the consumer non-durables company at the end of 2017Q3, valued at $6.84 million, up from 117,179 at the end of the previous reported quarter. Matrix Asset Advisors Inc who had been investing in General Mills for a number of months, seems to be bullish on the $32.11B market cap company. The stock decreased 0.81% or $0.46 during the last trading session, reaching $56.43. About 3.42 million shares traded. General Mills, Inc. (NYSE:GIS) has declined 10.63% since February 18, 2017 and is downtrending. It has underperformed by 27.33% the S&P500.

Since August 16, 2017, it had 0 insider purchases, and 6 insider sales for $58.12 million activity. Roberts Jonathan C sold $7.13M worth of CVS Health Corporation (NYSE:CVS) on Monday, September 18. MERLO LARRY J sold $20.03M worth of stock. $3.22M worth of CVS Health Corporation (NYSE:CVS) shares were sold by Foulkes Helena. Shares for $7.19M were sold by Moriarty Thomas M on Monday, September 11. Another trade for 237,078 shares valued at $18.88M was made by Denton David M on Monday, September 11.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.04, from 0.92 in 2017Q2. It is negative, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Advisor Ltd Llc reported 27,695 shares. Cohen & Steers holds 0.04% or 191,794 shares. 166,717 were reported by Fort Washington Inv Advsr Inc Oh. Hanson Mcclain Inc holds 0% or 302 shares. Addenda Capital owns 0.36% invested in CVS Health Corporation (NYSE:CVS) for 63,703 shares. Wright Investors Ser reported 32,861 shares. Parthenon Limited holds 3.32% or 173,133 shares. Clarivest Asset Ltd Company holds 190,968 shares. Arete Wealth Lc reported 9,200 shares stake. Paradigm Asset Mngmt Lc owns 37,470 shares for 0.79% of their portfolio. Mathes invested in 4,684 shares. Bank has invested 0.25% of its portfolio in CVS Health Corporation (NYSE:CVS). Putnam Fl Management invested 0.65% in CVS Health Corporation (NYSE:CVS). Arrow Financial owns 24,842 shares or 0.48% of their US portfolio. Teacher Retirement Systems Of Texas reported 830,569 shares stake.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 72 analyst reports since July 22, 2015 according to SRatingsIntel. RBC Capital Markets maintained CVS Health Corporation (NYSE:CVS) rating on Wednesday, August 5. RBC Capital Markets has “Outperform” rating and $132 target. The firm earned “Buy” rating on Friday, April 28 by Tigress Financial. The company was maintained on Wednesday, November 9 by Mizuho. The firm has “Neutral” rating given on Friday, November 3 by Citigroup. On Friday, August 28 the stock rating was maintained by Oppenheimer with “Outperform”. Tigress Financial maintained the shares of CVS in report on Tuesday, December 26 with “Buy” rating. Vetr upgraded CVS Health Corporation (NYSE:CVS) rating on Monday, August 24. Vetr has “Buy” rating and $117.98 target. The stock has “Overweight” rating by Barclays Capital on Thursday, March 10. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Wednesday, August 16 by Wolfe Research. Jefferies maintained the stock with “Hold” rating in Wednesday, August 16 report.

Since January 9, 2018, it had 0 buys, and 1 insider sale for $517,458 activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts